Global Diabetes Market Report: 2015 Edition
Diabetes mellitus, or simply diabetes, is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Insulin is a hormone made by the pancreas that acts like a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. All carbohydrate foods are broken down into glucose in the blood. Insulin helps glucose get into the cells. Type 1 diabetes, Type 2 diabetes and Gestational diabetes are the three types of diabetes. There are mainly three types of diabetes treatment which include insulin, oral anti-diabetic drug (OAD) and glucagon-like-peptide-1 (GLP-1).
The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with an in-depth study of the regional markets. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Novo-Nordisk, Sanofi-Aventis, Eli Lilly and Takeda are being profiled.
The key factors driving the growth of the diabetes market are growing evidence of insulin therapy, rising healthcare expenditure, rising obese population, increasing urbanization and ageing population. Some of the noteworthy trends and developments of this industry are increasing prevalence of diabetes, rising diabetes cases due to second hand smoke, and rise of impaired glucose tolerance (IGT). However, the expansion of global diabetes market is hindered by increasing treatment cost and lack of sufficient diagnosis and treatment facilities.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with an in-depth study of the regional markets. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Novo-Nordisk, Sanofi-Aventis, Eli Lilly and Takeda are being profiled.
The key factors driving the growth of the diabetes market are growing evidence of insulin therapy, rising healthcare expenditure, rising obese population, increasing urbanization and ageing population. Some of the noteworthy trends and developments of this industry are increasing prevalence of diabetes, rising diabetes cases due to second hand smoke, and rise of impaired glucose tolerance (IGT). However, the expansion of global diabetes market is hindered by increasing treatment cost and lack of sufficient diagnosis and treatment facilities.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. INTRODUCTION TO DIABETES
2. GLOBAL DIABETES MARKET
Diabetic Population
Prevalence Rates
Treatment Market Value
Insulin Market Value
Insulin Segments
Breakdown by Region
3. REGIONAL ANALYSIS
3.1 The Western Pacific
3.1.1 China
3.1.2 Japan
3.1.3 Other Countries
3.2 South-East Asia
3.2.1 India
3.2.2 Other Countries
3.3 Europe
3.3.1 Germany
3.3.2 Other Countries
3.4 North America and Caribbean
3.4.1 The US
3.4.2 Other Countries
3.5 Middle East and North Africa
3.5.1 Other Countries
3.6 South and Central America
3.6.1 Other Countries
3.7 Africa
3.7.1 Other Countries
4. MARKET DYNAMICS
4.1 Key Trends and Developments
4.1.1 Introduction of Artificial Pancreas System
4.1.2 Increasing Prevalence of Diabetes
4.1.3 Rising Diabetes Due to Second Hand Smoke
4.1.4 Rise of Impaired glucose tolerance (IGT)
4.1.5 Introduction Changing Diabetes Programme
4.1.6 Family History and Genetics
4.2 Growth Drivers
4.2.1 Growing Evidence for Insulin Therapy
4.2.2 Ageing Population Worldwide
4.2.3 Increasing Urbanization
4.2.4 Rising Healthcare Expenditure
4.2.5 Economic Growth
4.2.6 Rising Obese Population
4.3 Challenges
4.3.1 Increasing Diabetes Cost
4.3.2 Lack of Sufficient Diagnosis and Treatment
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.2 Regional
5.2.1 The US
5.2.2 Europe
5.2.3 China
5.2.4 Japan
6. COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Sanofi
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Eli Lilly
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Takeda
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
7. MARKET OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
2. GLOBAL DIABETES MARKET
Diabetic Population
Prevalence Rates
Treatment Market Value
Insulin Market Value
Insulin Segments
Breakdown by Region
3. REGIONAL ANALYSIS
3.1 The Western Pacific
3.1.1 China
3.1.2 Japan
3.1.3 Other Countries
3.2 South-East Asia
3.2.1 India
3.2.2 Other Countries
3.3 Europe
3.3.1 Germany
3.3.2 Other Countries
3.4 North America and Caribbean
3.4.1 The US
3.4.2 Other Countries
3.5 Middle East and North Africa
3.5.1 Other Countries
3.6 South and Central America
3.6.1 Other Countries
3.7 Africa
3.7.1 Other Countries
4. MARKET DYNAMICS
4.1 Key Trends and Developments
4.1.1 Introduction of Artificial Pancreas System
4.1.2 Increasing Prevalence of Diabetes
4.1.3 Rising Diabetes Due to Second Hand Smoke
4.1.4 Rise of Impaired glucose tolerance (IGT)
4.1.5 Introduction Changing Diabetes Programme
4.1.6 Family History and Genetics
4.2 Growth Drivers
4.2.1 Growing Evidence for Insulin Therapy
4.2.2 Ageing Population Worldwide
4.2.3 Increasing Urbanization
4.2.4 Rising Healthcare Expenditure
4.2.5 Economic Growth
4.2.6 Rising Obese Population
4.3 Challenges
4.3.1 Increasing Diabetes Cost
4.3.2 Lack of Sufficient Diagnosis and Treatment
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.2 Regional
5.2.1 The US
5.2.2 Europe
5.2.3 China
5.2.4 Japan
6. COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Sanofi
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Eli Lilly
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Takeda
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
7. MARKET OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
LIST OF CHARTS
Types of Diabetes
Global Diabetic Population (2006-2014)
Global Diabetes Population by Region (2014)
Global Diabetes Prevalence Rates (2014)
Top Ten Countries with Lowest Cost per Patient with Diabetes (2014)
Diabetes Treatment Product Market by Value (2014)
Diabetes Market by Treatment Product (2014)
Global Insulin Market (2012-2015E)
Global Insulin Market by Segments (2014)
Global Insulin Market by Geographical Segments (2014)
GLP-1 Market share by Region (2014)
Chinese Insulin Market by Segment (2014)
Japan Insulin Market by Segment (2014)
Top Countries by Diabetes Cases in South East Asia (2014)
European Insulin Market by Segment (2014)
Top Countries by Diabetes Cases in North America and Caribbean (2014)
The US Insulin Market by Segment (2014)
Diagnosed Diabetes in Canada (2007-2014)
Top Countries by Diabetes Case in Middle East and North Africa (2014)
Ageing Population Worldwide (2006-2014)
Global Urban Populations (2007-2014)
Global Healthcare Expenditure (2007-2014)
Global GDP Growth (2006-2014)
Growth in Worldwide Obese Population (2006-2014)
Global Diabetes Market Share by Company (2014)
Modern Insulin Market in the US by Volume (2014)
Modern Insulin Market in Europe by Volume (2014)
Insulin Market Share in China by Volume (2014)
Modern Insulin Market Share in Japan by Volume (2014)
Novo Nordisk’s Revenue Share by Business Segments (2014)
Novo Nordisk’s Net Sales Share by Region (2014)
Novo Nordisk’s Net Sales and Profit (2010-2014)
Sanofi’s Revenue Share by Business Segment (2014)
Sanofi’s Revenue Share by Region (2014)
Sanofi’s Net Sales and Net Income (2010-2014)
Eli Lilly’s Revenue Share by Business Segments (2014)
Eli Lilly’s Revenue Share by Region (2014)
Eli Lilly’s Revenues and Net Income (2010-2014)
Takeda’s Revenue Share by Business Segments (2014)
Takeda’s Revenue Share by Region (2014)
Takeda’s Revenues and Net Income (2010-2014)
Global Diabetic Population Forecast (2014-2018E)
Types of Diabetes
Global Diabetic Population (2006-2014)
Global Diabetes Population by Region (2014)
Global Diabetes Prevalence Rates (2014)
Top Ten Countries with Lowest Cost per Patient with Diabetes (2014)
Diabetes Treatment Product Market by Value (2014)
Diabetes Market by Treatment Product (2014)
Global Insulin Market (2012-2015E)
Global Insulin Market by Segments (2014)
Global Insulin Market by Geographical Segments (2014)
GLP-1 Market share by Region (2014)
Chinese Insulin Market by Segment (2014)
Japan Insulin Market by Segment (2014)
Top Countries by Diabetes Cases in South East Asia (2014)
European Insulin Market by Segment (2014)
Top Countries by Diabetes Cases in North America and Caribbean (2014)
The US Insulin Market by Segment (2014)
Diagnosed Diabetes in Canada (2007-2014)
Top Countries by Diabetes Case in Middle East and North Africa (2014)
Ageing Population Worldwide (2006-2014)
Global Urban Populations (2007-2014)
Global Healthcare Expenditure (2007-2014)
Global GDP Growth (2006-2014)
Growth in Worldwide Obese Population (2006-2014)
Global Diabetes Market Share by Company (2014)
Modern Insulin Market in the US by Volume (2014)
Modern Insulin Market in Europe by Volume (2014)
Insulin Market Share in China by Volume (2014)
Modern Insulin Market Share in Japan by Volume (2014)
Novo Nordisk’s Revenue Share by Business Segments (2014)
Novo Nordisk’s Net Sales Share by Region (2014)
Novo Nordisk’s Net Sales and Profit (2010-2014)
Sanofi’s Revenue Share by Business Segment (2014)
Sanofi’s Revenue Share by Region (2014)
Sanofi’s Net Sales and Net Income (2010-2014)
Eli Lilly’s Revenue Share by Business Segments (2014)
Eli Lilly’s Revenue Share by Region (2014)
Eli Lilly’s Revenues and Net Income (2010-2014)
Takeda’s Revenue Share by Business Segments (2014)
Takeda’s Revenue Share by Region (2014)
Takeda’s Revenues and Net Income (2010-2014)
Global Diabetic Population Forecast (2014-2018E)
LIST OF TABLES
Global Diabetes Statistics (2014)
Western Pacific - Diabetes Statistics (2014)
China - Diabetes Statistics (2014)
Japan - Diabetes Statistics (2014)
Diabetes in Other Major Countries of Western Pacific (2014)
South-East Asia – Diabetes Statistics (2014)
India – Diabetes Statistics (2014)
Diabetes in Other Countries of South East Asia (2014)
Europe – Diabetes Statistics (2014)
Germany – Diabetes Statistics (2014)
Diabetes in Other Countries of Europe (2014)
North America and Caribbean – Diabetes Statistics (2014)
Diabetes in the US (2014)
Type 1 Insulin Pump Presence by Region (2014)
Diabetes in Other Countries of the North American and Caribbean Region (2014)
Middle East and North Africa – Diabetes Statistics (2014)
Diabetes in Other Countries of the Middle East and North Africa Region (2014)
South and Central America – Diabetes Statistics (2014)
Diabetes in Other Countries of the South and Central America Region (2014)
Africa – Diabetes Statistics (2014)
Diabetes in Other Countries of Africa Region (2014)
Diabetes Brands Sales by Company (2014)
Dependent & Independent Variables (2009-2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Global Diabetes Statistics (2014)
Western Pacific - Diabetes Statistics (2014)
China - Diabetes Statistics (2014)
Japan - Diabetes Statistics (2014)
Diabetes in Other Major Countries of Western Pacific (2014)
South-East Asia – Diabetes Statistics (2014)
India – Diabetes Statistics (2014)
Diabetes in Other Countries of South East Asia (2014)
Europe – Diabetes Statistics (2014)
Germany – Diabetes Statistics (2014)
Diabetes in Other Countries of Europe (2014)
North America and Caribbean – Diabetes Statistics (2014)
Diabetes in the US (2014)
Type 1 Insulin Pump Presence by Region (2014)
Diabetes in Other Countries of the North American and Caribbean Region (2014)
Middle East and North Africa – Diabetes Statistics (2014)
Diabetes in Other Countries of the Middle East and North Africa Region (2014)
South and Central America – Diabetes Statistics (2014)
Diabetes in Other Countries of the South and Central America Region (2014)
Africa – Diabetes Statistics (2014)
Diabetes in Other Countries of Africa Region (2014)
Diabetes Brands Sales by Company (2014)
Dependent & Independent Variables (2009-2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
